A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial
Titel:
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial
Auteur:
Hortobagyi, G.N. Lacko, A. Sohn, J. Cruz, F. Ruiz Borrego, M. Manikhas, A. Hee Park, Y. Stroyakovskiy, D. Yardley, D.A. Huang, C.-S. Fasching, P.A. Crown, J. Bardia, A. Chia, S. Im, S.-A. Martin, M. Loi, S. Xu, B. Hurvitz, S. Barrios, C. Untch, M. Moroose, R. Visco, F. Parnizari, F. Zarate, J.P. Li, Z. Waters, S. Chakravartty, A. Slamon, D.